SCHEMBL19106356

SCHEMBL19106356

c1ccc(-c2cc(-c3cc(-c4ccccc4)nc(-c4ccccc4)n3)cc(-c3nc(-c4ccccc4)c4sc5ccccc5c4n3)c2)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 9/20 0.39
▸ KMT2A Q03164 9/20 0.39
▸ ALDH1A1 P00352 6/20 0.39
▸ HPGD P15428 6/20 0.39
▸ MAPT P10636 5/20 0.39
▸ NTSR1 P30989 1/20 0.39
▸ ADORA2A P29274 2/20 0.37
▸ ADORA1 P30542 2/20 0.37
▸ KDM4E B2RXH2 3/20 0.35
▸ LMNA P02545 2/20 0.35
▸ ATM Q13315 1/20 0.35
▸ GLA P06280 1/20 0.35
▸ TNKS O95271 2/20 0.34
▸ TNKS2 Q9H2K2 2/20 0.34
▸ KRAS P01116 1/20 0.34
▸ MAPK1 P28482 1/20 0.34
▸ TDP1 Q9NUW8 1/20 0.34
▸ LIMK1 P53667 3/20 0.34
▸ WHR1 P49842 1/20 0.33
▸ SMN1; SMN2 Q16637 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19106357 1.00 MEN1 (0.39) MEN1KMT2AALDH1A1HPGDMAPT
SCHEMBL19106361 0.99 MEN1 (0.37) MEN1KMT2AALDH1A1HPGDMAPT
SCHEMBL19106365 0.99 MEN1 (0.37) MEN1KMT2AALDH1A1HPGDMAPT
SCHEMBL19106359 0.98 MEN1 (0.38) MEN1KMT2AALDH1A1HPGDMAPT
SCHEMBL19106364 0.96 MEN1 (0.37) MEN1KMT2AALDH1A1HPGDMAPT
SCHEMBL16581161 0.94 TNKS (0.36) MEN1KMT2AALDH1A1HPGDMAPT
SCHEMBL16581157 0.94 TNKS (0.36) MEN1KMT2AALDH1A1HPGDMAPT
SCHEMBL19106211 0.94 MEN1 (0.45) MEN1KMT2AALDH1A1HPGDMAPT
SCHEMBL19106308 0.94 MEN1 (0.45) MEN1KMT2AALDH1A1HPGDMAPT
SCHEMBL19106386 0.94 MEN1 (0.40) MEN1KMT2AHPGDMAPTADORA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10734588-B2 Compound for organic electronic element, and organic electronic element and electronic device using same DUK SAN NEOLUX CO., LTD (KR) 2020-08-04 — — US disclosed
US-20170200903-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, AND ORGANIC ELECTRONIC ELEMENT AND ELECTRONIC DEVICE USING SAME DUK SAN NEOLUX CO., LTD. (KR) 2017-07-13 — — US disclosed
US-20170200903-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, AND ORGANIC ELECTRONIC ELEMENT AND ELECTRONIC DEVICE USING SAME DUK SAN NEOLUX CO., LTD. (KR) 2017-07-13 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170200903-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, AND ORGANIC ELECTRONIC ELEMENT AND ELECTRONIC DEVICE USING SAME NFE2L2, ESR1, VDAC2 MEN1 1003/4885KMT2A 581/4885ALDH1A1 1024/4885
US-10734588-B2 Compound for organic electronic element, and organic electronic element and electronic device using same NFE2L2, ESR1, VDAC2 MEN1 1003/4885KMT2A 581/4885ALDH1A1 1024/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback